Advertisement

USPSTF Draft Recommendation Advises Aspirin for Women at Risk for Preeclampsia — Physician’s First Watch

Medical News |
April 8, 2014

USPSTF Draft Recommendation Advises Aspirin for Women at Risk for Preeclampsia

By Kelly Young

The U.S. Preventive Services Task Force is recommending the use of low-dose aspirin (81 mg/day) to prevent preeclampsia in high-risk women. Previously, the group found insufficient evidence to recommend its routine use.

In a draft recommendation statement, the task force advises daily, low-dose aspirin after 12 weeks' gestation if a woman has one or more high-risk conditions, such as a history of preeclampsia, chronic hypertension, or diabetes, or has several moderate risk factors, including obesity, family history, and an age of 35 years or above.

Clinical trials found that aspirin reduced the risk for preeclampsia by 24%, preterm birth by 14%, and intrauterine growth restriction by 20%. There was no evidence of maternal or fetal harms with aspirin.

The authors write that aspirin's anti-inflammatory, antiangiogenesis, and antiplatelet properties could help explain its role in preeclampsia prevention.

The USPSTF's draft statement is open to public comment until May 5.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement